The bioterrorism expert finally completed its smallpox vaccine contract with the U.S. government.
News & Analysis: Emergent BioSolutions
In an unprecedented move, the agency is doing some of the legwork for the companies.
The U.S. government wants more of its smallpox vaccine.
The bioterrorism expert still has some negotiating with the government to do.
EBS earnings call for the period ending June 30, 2019.
These look like great picks to buy in May before you go away.
A new government contract for smallpox vaccine, ACAM2000, is still in the works.
These three biotech stocks could be prime comeback candidates.
Shares drop after the company reports first-quarter results that missed the mark.
EBS earnings call for the period ending March 31, 2019.